- Home
- OSUR vs VYGR Comparison
OSUR vs VYGR Comparison
Compare OSUR & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- VYGR
- Stock Information
- Founded
- OSUR 2000
- VYGR 2013
- Country
- OSUR United States
- VYGR United States
- Employees
- OSUR N/A
- VYGR N/A
- Industry
- OSUR Medical/Dental Instruments
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- OSUR Health Care
- VYGR Health Care
- Exchange
- OSUR Nasdaq
- VYGR Nasdaq
- Market Cap
- OSUR 248.3M
- VYGR 222.9M
- IPO Year
- OSUR 1986
- VYGR 2015
- Fundamental
- Price
- OSUR $3.37
- VYGR $3.41
- Analyst Decision
- OSUR Hold
- VYGR Strong Buy
- Analyst Count
- OSUR 2
- VYGR 9
- Target Price
- OSUR $5.50
- VYGR $14.86
- AVG Volume (30 Days)
- OSUR 699.3K
- VYGR 371.0K
- Earning Date
- OSUR 05-07-2025
- VYGR 03-11-2025
- Dividend Yield
- OSUR N/A
- VYGR N/A
- EPS Growth
- OSUR N/A
- VYGR N/A
- EPS
- OSUR N/A
- VYGR N/A
- Revenue
- OSUR $185,827,000.00
- VYGR $80,001,000.00
- Revenue This Year
- OSUR N/A
- VYGR N/A
- Revenue Next Year
- OSUR $7.46
- VYGR $23.46
- P/E Ratio
- OSUR N/A
- VYGR N/A
- Revenue Growth
- OSUR N/A
- VYGR N/A
- 52 Week Low
- OSUR $2.69
- VYGR $3.26
- 52 Week High
- OSUR $6.35
- VYGR $9.72
- Technical
- Relative Strength Index (RSI)
- OSUR 45.10
- VYGR 30.44
- Support Level
- OSUR $3.34
- VYGR $3.26
- Resistance Level
- OSUR $3.56
- VYGR $3.96
- Average True Range (ATR)
- OSUR 0.15
- VYGR 0.22
- MACD
- OSUR -0.00
- VYGR -0.02
- Stochastic Oscillator
- OSUR 10.53
- VYGR 16.48
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.